Home » Ex-Biotech CEO to Pay SEC More Than $1.1 Million
Ex-Biotech CEO to Pay SEC More Than $1.1 Million
A former Transkaryotic Therapies executive agreed to pay more than $1.1 million to settle claims that he misled investors about problems facing the Cambridge biotech company's flagship drug, the government said.
Boston.com
Boston.com
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May